Methodological considerations on real-world evidence studies of monoclonal antibodies against the CGRP-pathway for migraine: a systematic review

被引：0
|
作者：
Nicolas Vandenbussche
Karolina Pisarek
Koen Paemeleire
机构：
[1] Ghent University Hospital,Department of Neurology
[2] Ghent University,Faculty of Medicine and Health Sciences
来源：
The Journal of Headache and Pain | / 24卷
关键词：
Methodology; Migraine; CGRP; Real-world evidence; Clinical trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Methodological considerations on real-world evidence studies of monoclonal antibodies against the CGRP-pathway for migraine: a systematic review
    Vandenbussche, Nicolas
    Pisarek, Karolina
    Paemeleire, Koen
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [2] Real-world evidence for frequency of constipation with the use of anti-CGRP monoclonal antibodies in chronic migraine
    Uzun, S.
    Frejvall, U.
    Sahin, G. Ozkaya
    Sahin, G.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [3] Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data
    Sanchez-Rodriguez, Carmen
    Gago-Veiga, Ana Beatriz
    Garcia-Azorin, David
    Guerrero-Peral, Angel Luis
    Gonzalez-Martinez, Alicia
    CURRENT PAIN AND HEADACHE REPORTS, 2024, 28 (12) : 1265 - 1272
  • [4] The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
    Torres-Ferrus, Marta
    Gallardo, Victor J.
    Alpuente, Alicia
    Caronna, Edoardo
    Gine-Cipres, Eulalia
    Pozo-Rosich, Patricia
    JOURNAL OF NEUROLOGY, 2021, 268 (10) : 3789 - 3798
  • [5] Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study
    Alpuente, Alicia
    Torre-Sune, Anna
    Caronna, Edoardo
    Gine-Cipres, Eulalia
    Torres-Ferrus, Marta
    Pozo-Rosich, Patricia
    CEPHALALGIA, 2023, 43 (08)
  • [6] The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
    Marta Torres-Ferrús
    Victor J. Gallardo
    Alicia Alpuente
    Edoardo Caronna
    Eulalia Gine-Cipres
    Patricia Pozo-Rosich
    Journal of Neurology, 2021, 268 : 3789 - 3798
  • [7] Monoclonal Antibodies against Calcitonin Gene-Related Peptide for Migraine Prophylaxis: A Systematic Review of Real-World Data
    Pavelic, Antun R.
    Woeber, Christian
    Riederer, Franz
    Zebenholzer, Karin
    CELLS, 2023, 12 (01)
  • [8] Real-World Effectiveness of Eptinezumab after Treatment with Subcutaneous CGRP Monoclonal Antibodies in Patients with Migraine
    Casaletto, Emily
    Yang, Qiu Zi
    Waters, John
    Curran, John
    Lowe, Austin
    Yuan, Hsiangkuo
    NEUROLOGY, 2023, 100 (17)
  • [9] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review
    Salim, Amira
    Hennessy, Elise
    Sonneborn, Claire
    Hogue, Olivia
    Biswas, Sudipa
    Mays, Maryann
    Suneja, Aarushi
    Ahmed, Zubair
    Mata, Ignacio F.
    CNS DRUGS, 2024, 38 (06) : 481 - 491
  • [10] Effectiveness and tolerability of monoclonal antibodies targeting CGRP pathway for migraine prevention: Real-world data from the Migraine Registry (ReMig) in the Czech Republic
    Nezadal, T.
    Dolezal, T.
    Pejrilova, D.
    Turkova, B.
    Markova, J.
    Bartkova, A.
    Klecka, L.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
12345